CARDIFF: APRIL 2010

Christopher Wood to present at Wales Cancer Conference in Cardiff, 14th - 15th April 2010.

EDINBURGH: FEBRUARY 2010

Hugh Griffith to present at BIA Scotland BioLeadership Forum and Dinner, 4th February 2010.

EDINBURGH: 18 December 2009
NuCana BioMed Completes Financing to Expand Anti-Cancer Drug Development Programme

NuCana BioMed Ltd ("NuCana") today announced it had completed a further equity financing that will allow the company to rapidly expand its drug development programme of new anti-cancer agents.

EDINBURGH: 18 December 2009
Alida Capital International Completes Financing into NuCana BioMed
Alida Capital International Ltd ("Alida") today announced it had completed an equity financing into Edinburgh based biopharmaceutical company NuCana BioMed ("NuCana"). The Scottish Enterprise Scottish Co-Investment Fund participated in the round.
CARDIFF: 18 November 2009
Morvus Technology and NuCana BioMed sign exclusive world-wide licence to develop ProTide Technology in Cancer
Morvus Technology Ltd ("Morvus") and NuCana BioMed Ltd ("NuCana") today announce that an agreement has been signed by which Morvus has granted to NuCana an exclusive, world-wide, licence with rights to develop its ProTide technology for the enhancement of nucleoside analogues ("nucleosides").